The case:
-
1
Dong-A has great assets
A consumer health business led by Bacchus that has earned a 12% operating margin and a return on equity above 30% for twelve years, the best among Korean OTC peers.
-
2
These assets should make Dong-A worth 3x today
Valued on their own results, intrinsically or against Dongkook and global consumer health peers, Dong-A is worth about 261,200 KRW per share.
-
3
Instead, the discount keeps widening
Over the last decade Dong-A's price to book has halved while the KOSPI tripled shareholders' money.
-
4
Bad governance led to bad allocation, and bad allocation to a widening discount
Dong-A has put capital into its worst-performing businesses and kept dividends low, with no buybacks since 2020, while its shares traded far below fair value.
-
5
Five changes would fix it
Each is a Board decision that can be made at or before the March 2027 AGM. We have asked the Board to respond in writing by December 4.
-
6
Why Korea should care
The National Pension Service and Dong-A's employee stock ownership association together own 18% of the company. Better returns mean more capital to innovate, grow and hire.